Distigmine

Distigmine (as distigmine bromide) is a parasympathomimetic that inhibit cholinesterases. Distigmine is similar to pyridostigmine and neostigmine but has a longer duration of action. It is available as tablets on prescription only. Distigmine has a greater risk of causing cholinergic crisis because of accumulation of the drug being more likely than with neostigmine or pyridostigmine and so distigmine is rarely used as a treatment for myasthenia gravis, unlike pyridostigmine and neostigmine.

General

Type : Carbamate,Drug,Pyridine

Chemical_Nomenclature : (1-methylpyridin-1-ium-3-yl) N-methyl-N-[6-[methyl-(1-methylpyridin-1-ium-3-yl)oxycarbonylamino]hexyl]carbamate

Canonical SMILES : C[N+]1=CC=CC(=C1)OC(=O)N(C)CCCCCCN(C)C(=O)OC2=C[N+](=CC=C2)C

InChI : InChI=1S\/C22H32N4O4\/c1-23-13-9-11-19(17-23)29-21(27)25(3)15-7-5-6-8-16-26(4)22(28)30-20-12-10-14-24(2)18-20\/h9-14,17-18H,5-8,15-16H2,1-4H3\/q+2

InChIKey : AHZBEVXBKNYXPU-UHFFFAOYSA-N

Other name(s) : UNII-T940307O7B,CHEBI:80756,AC1L1F7E,CHEMBL1199307,SCHEMBL16674116,Distigmine bromide,Hexamarium


MW : 416.52

Formula : C22H32N4O4+2

CAS_number : 17299-00-2

PubChem : 3116

UniChem : AHZBEVXBKNYXPU-UHFFFAOYSA-N

IUPHAR :

Wikipedia : Distigmine

Target

Families : Distigmine ligand of proteins in family: BCHE

Stucture :

Protein :

References (17)

Title : Distigmine Bromide Produces Sustained Potentiation of Guinea-Pig Urinary Bladder Motility by Inhibiting Cholinesterase Activity - Obara_2017_Biol.Pharm.Bull_40_807
Author(s) : Obara K , Chino D , Tanaka Y
Ref : Biol Pharm Bull , 40 :807 , 2017
Abstract : Obara_2017_Biol.Pharm.Bull_40_807
ESTHER : Obara_2017_Biol.Pharm.Bull_40_807
PubMedSearch : Obara_2017_Biol.Pharm.Bull_40_807
PubMedID: 28566624

Title : The Long-Lasting Enhancing Effect of Distigmine on Acetylcholine-Induced Contraction of Guinea Pig Detrusor Smooth Muscle Correlates with Its Anticholinesterase Activity - Obara_2017_Biol.Pharm.Bull_40_1092
Author(s) : Obara K , Ogawa T , Chino D , Tanaka Y
Ref : Biol Pharm Bull , 40 :1092 , 2017
Abstract : Obara_2017_Biol.Pharm.Bull_40_1092
ESTHER : Obara_2017_Biol.Pharm.Bull_40_1092
PubMedSearch : Obara_2017_Biol.Pharm.Bull_40_1092
PubMedID: 28674252

Title : Effect of distigmine on the contractile response of guinea pig urinary bladder to electrical field stimulation - Obara_2017_Eur.J.Pharmacol_809_209
Author(s) : Obara K , Kobayashi Y , Chino D , Tanaka Y
Ref : European Journal of Pharmacology , 809 :209 , 2017
Abstract : Obara_2017_Eur.J.Pharmacol_809_209
ESTHER : Obara_2017_Eur.J.Pharmacol_809_209
PubMedSearch : Obara_2017_Eur.J.Pharmacol_809_209
PubMedID: 28511871

Title : Long-Lasting Inhibitory Effects of Distigmine on Recombinant Human Acetylcholinesterase Activity - Obara_2017_Biol.Pharm.Bull_40_1739
Author(s) : Obara K , Chino D , Tanaka Y
Ref : Biol Pharm Bull , 40 :1739 , 2017
Abstract : Obara_2017_Biol.Pharm.Bull_40_1739
ESTHER : Obara_2017_Biol.Pharm.Bull_40_1739
PubMedSearch : Obara_2017_Biol.Pharm.Bull_40_1739
PubMedID: 28966245

Title : [Bowel obstruction-induced cholinergic crisis with progressive respiratory failure following distigmine bromide treatment] - Kobayashi_2016_Chudoku.Kenkyu_29_26
Author(s) : Kobayashi K , Sekiguchi H , Sato N , Hirose Y
Ref : Chudoku Kenkyu , 29 :26 , 2016
Abstract : Kobayashi_2016_Chudoku.Kenkyu_29_26
ESTHER : Kobayashi_2016_Chudoku.Kenkyu_29_26
PubMedSearch : Kobayashi_2016_Chudoku.Kenkyu_29_26
PubMedID: 27255021

Title : Effects of Silodosin, an alpha-Adrenoceptor Antagonist, and Distigmine, an Acetylcholinesterase Inhibitor, and Their Combined Effects on Impaired Voiding Function in Zucker Diabetic Fatty Rats - Tatemichi_2015_Pharmacology_95_285
Author(s) : Tatemichi S , Tsuchioka K , Yonekubo S , Maruyama K , Kobayashi M
Ref : Pharmacology , 95 :285 , 2015
Abstract : Tatemichi_2015_Pharmacology_95_285
ESTHER : Tatemichi_2015_Pharmacology_95_285
PubMedSearch : Tatemichi_2015_Pharmacology_95_285
PubMedID: 26023044

Title : Effects of bethanechol chloride and distigmine bromide on postvoiding residual volume in patients with underactive bladder - Izumi_2014_Minerva.Urol.Nefrol_66_241
Author(s) : Izumi K , Maolake A , Maeda Y , Shigehara K , Namiki M
Ref : Minerva Urol Nefrol , 66 :241 , 2014
Abstract : Izumi_2014_Minerva.Urol.Nefrol_66_241
ESTHER : Izumi_2014_Minerva.Urol.Nefrol_66_241
PubMedSearch : Izumi_2014_Minerva.Urol.Nefrol_66_241
PubMedID: 25531193

Title : Effect of distigmine combined with propiverine on bladder activity in rats with spinal cord injury - Sugaya_2012_Int.J.Urol_19_480
Author(s) : Sugaya K , Nishijima S , Kadekawa K , Ashitomi K , Yamamoto H
Ref : Int J Urol , 19 :480 , 2012
Abstract : Sugaya_2012_Int.J.Urol_19_480
ESTHER : Sugaya_2012_Int.J.Urol_19_480
PubMedSearch : Sugaya_2012_Int.J.Urol_19_480
PubMedID: 22221137

Title : Marked hydronephrosis and hydroureter after distigmine therapy in an adult male patient with paraplegia due to spinal cord injury: a case report - Vaidyanathan_2009_Cases.J_2_7333
Author(s) : Vaidyanathan S , Mansour P , Soni BM , Hughes PL , Singh G , Oo T
Ref : Cases J , 2 :7333 , 2009
Abstract : Vaidyanathan_2009_Cases.J_2_7333
ESTHER : Vaidyanathan_2009_Cases.J_2_7333
PubMedSearch : Vaidyanathan_2009_Cases.J_2_7333
PubMedID: 19918519

Title : Effect of distigmine bromide on the central cholinergic system - Nakayama_2009_J.Psychopharmacol_23_190
Author(s) : Nakayama K , Katsu H , Kitazumi K
Ref : J Psychopharmacol , 23 :190 , 2009
Abstract : Nakayama_2009_J.Psychopharmacol_23_190
ESTHER : Nakayama_2009_J.Psychopharmacol_23_190
PubMedSearch : Nakayama_2009_J.Psychopharmacol_23_190
PubMedID: 18515453

Title : Nocturnal hypersalivation caused by distigmine bromide in a patient with multiple system atrophy -
Author(s) : Suzuki K , Miyamoto T , Miyamoto M , Hirata K
Ref : Intern Med , 47 :983 , 2008
PubMedID: 18480587

Title : [Acute poisoning due to distigmine bromide] -
Author(s) : Onodera M
Ref : Chudoku Kenkyu , 21 :161 , 2008
PubMedID: 18516941

Title : [A case of acute distigmine bromide intoxication in the therapeutic dosage for treatment of underactive neurogenic bladder] - Tada_2004_No.To.Shinkei_56_415
Author(s) : Tada M , Fujita N , Umeda M , Koike H , Nagai H
Ref : No To Shinkei , 56 :415 , 2004
Abstract : Tada_2004_No.To.Shinkei_56_415
ESTHER : Tada_2004_No.To.Shinkei_56_415
PubMedSearch : Tada_2004_No.To.Shinkei_56_415
PubMedID: 15279199

Title : [Cholinergic crisis following administration of distigmine bromide: a case report] - Yamanaka_2002_Hinyokika.Kiyo_48_21
Author(s) : Yamanaka S , Fujita I , Murota T , Kawakita M , Matsuda T
Ref : Hinyokika Kiyo , 48 :21 , 2002
Abstract : Yamanaka_2002_Hinyokika.Kiyo_48_21
ESTHER : Yamanaka_2002_Hinyokika.Kiyo_48_21
PubMedSearch : Yamanaka_2002_Hinyokika.Kiyo_48_21
PubMedID: 11868380

Title : Absolute bioavailability, pharmacokinetics, renal and biliary clearance of distigmine after a single oral dose in comparison to i.v. administration of 14C-distigmine-bromide in healthy volunteers - Vree_1999_Int.J.Clin.Pharmacol.Ther_37_393
Author(s) : Vree TB , Waitzinger J , Hammermaier A , Radhofer-Welte S
Ref : Int J Clinical Pharmacology & Therapeutics , 37 :393 , 1999
Abstract : Vree_1999_Int.J.Clin.Pharmacol.Ther_37_393
ESTHER : Vree_1999_Int.J.Clin.Pharmacol.Ther_37_393
PubMedSearch : Vree_1999_Int.J.Clin.Pharmacol.Ther_37_393
PubMedID: 10475142

Title : [Relationship between cholinergic symptoms caused by distigmine and the activities of serum AChE and BChE] - Koga_1997_Nihon.Shinkei.Seishin.Yakurigaku.Zasshi_17_143
Author(s) : Koga M , Miyata H , Tsuno N , Nakayama K , Ushijima S , Tanaka Y , Hiraga Y , Kobayashi N
Ref : Nihon Shinkei Seishin Yakurigaku Zasshi , 17 :143 , 1997
Abstract : Koga_1997_Nihon.Shinkei.Seishin.Yakurigaku.Zasshi_17_143
ESTHER : Koga_1997_Nihon.Shinkei.Seishin.Yakurigaku.Zasshi_17_143
PubMedSearch : Koga_1997_Nihon.Shinkei.Seishin.Yakurigaku.Zasshi_17_143
PubMedID: 9278940

Title : Inhibition of acetylcholinesterase by distigmine bromide (Ubretid) - Breuel_1993_Int.J.Clin.Pharmacol.Ther.Toxicol_31_230
Author(s) : Breuel HP , Bohn-Olszewsky W , Engelsen SJ , Samhaber EM , Niklaus H
Ref : International Journal of Clinical Pharmacology, Therapy, & Toxicology , 31 :230 , 1993
Abstract : Breuel_1993_Int.J.Clin.Pharmacol.Ther.Toxicol_31_230
ESTHER : Breuel_1993_Int.J.Clin.Pharmacol.Ther.Toxicol_31_230
PubMedSearch : Breuel_1993_Int.J.Clin.Pharmacol.Ther.Toxicol_31_230
PubMedID: 8100221